biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by BearDownAZon Oct 09, 2017 9:44pm

134 Views

Post# 26793059

RE:RE:RE:Where the heck?

That is an amazing new website. Great job team biOasis! The BBB and platform videos are very effective. And Mark Day nails it in his CEO video. Interesting three programs mentioned (brain metastases, glioblastoma and Parkinsons). I'm excited to hear more about their Parkinsons endeavor, but interesting that there was no mention of an ongoing LSD programs. Also, they mention that Connecticut offices opened last month. That's exciting. Love the new website. BearDownAZ

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale